業績一覧

ACHIEVEMENT LIST

  • Kano S, Kawakita D, Honma Y, Takahashi H, Hanazawa T, Tsukahara K, Fujii S, Okami K, Yamazaki K, Ueki Y, Saito Y, Ozawa H, Imaizumi S, Arai T, Iwaki S, Hanyu K, Yamauchi M, Tanaka R, Yamamura K, Sekimizu M, Fushimi C, Matsuki T, Utsumi Y, Nakaguro M, Nagao T, Tada Y, Multi‐institutional Joint SDC Study Group in Japan: Biomarker-Driven Initial Systemic Therapy Enabling Curative-Intent Treatment in Non-Metastatic Unresectable Salivary Duct Carcinoma: A Multi-Institutional Retrospective Study

    Head Neck. 2026 Jul 31, 2026

  • Kano S, Hamada S, Taguchi J, Tsushima N, Idogawa H, Imanari H, Kakumu M, Sakai M, Shimizu Y, Homma A: Histological heterogeneity of SLFN11 expression and its association with response to carboplatin plus paclitaxel therapy in salivary gland cancer

    Int J Clin Oncol. 2026 Sep 1, 2026

  • Kano S, Taguchi J, Maeda T, Suzuki T, Hamada S, Kato S, Saito A, Shimizu Y, Homma A: Conversion surgery following trastuzumab and docetaxel combination therapy for unresectable HER2-positive parotid gland cancer

    Auris Nasus Larynx. 53(3): 328-331, 2026

  • Fujiwara K, Morita S, Hoshino K, Takeda H, Komatsuda K, Nakamaru Y, Homma A: Comparison of post-operative vestibular function between vestibular schwannoma and non-vestibular schwannoma cerebellopontine angle tumors patients using video head impulse test

    J Vestib Res. 36(3): 183-190, 2026

  • Fujiwara K, Morita S, Yanagi H, Hoshino K, Takeda H, Komatsuda K, Nakamaru Y, Furuta Y, Homma A: Psychological outcomes of botulinum toxin treatment for facial nerve palsy sequelae: A retrospective analysis of anxiety and depression

    Auris Nasus Larynx. 53(3): 435-440, 2026

  • Fujiwara K, Morita S, Hoshino K, Takeda H, Komatsuda K, Ueda K, Nakamaru Y, Homma A: Safe administration of botulinum neurotoxin type A for facial nerve palsy sequelae in a patient with myasthenia gravis

    Auris Nasus Larynx. 53(5): 745-748, 2026

  • Tsushima N, Kano S, Suzuki T, Idogawa H, Kakumu M, Imanari H, Homma A: Resting heart rate as a prognostic indicator for patients with head and neck squamous cell carcinoma

    Int J Clin Oncol. 31(7): 1326-1335, 2026

  • Kamekura R, Kumai T, Suzuki M, Maeda E, Suzuki T, Izumi K, Takezaki S, Sakai H, Morita K, Sakashita T, Takamura K, Satoh T, Yamazoe M, Konno S, Ujiie H, Namba K, Ueki M, Minami Y, Nogami K, Wakisaka R, Kono M, Yamamoto K, Takahara M, Takano K, Homma A, Nakamaru Y: Prevalence of birch pollinosis and oral allergy syndrome in the general population of Hokkaido, Japan

    Auris Nasus Larynx. 53(4): 506-513, 2026

  • Tachibana H, Matsuura K, Onimaru R, Yoshida D, Kobayashi T, Ueda T, Nakahira M, Ohkoshi A, Omura G, Mukaigawa T, Katagiri K, Asakage T, Shinomiya H, Ito F, Asada Y, Beppu T, Fujii T, Hirayama Y, Tsukahara K, Saito Y, Ichikawa K, Uemura H, Tahara M, Hanai N, Kiyota N, Iwamoto S, Sasaki K, Mizusawa J, Fukuda H, Homma A, JCOG Head and Neck Cancer Study Group of the Japan Clinical Oncology Group (JCOG-HNCSG): Superselective intra-arterial chemoradiotherapy for maxillary sinus squamous-cell carcinoma: results from the T4bN0M0 cohort of JCOG1212

    ESMO Open. 11(8): 108336, 2026

  • Hayashi Y, Tanabe N, Shimizu K, Suzuki M, Sakamoto R, Sunadome H, Sato S, Kimura H, Makita H, Nishimura M, Sato A, Konno S, Hirai T: Paranasal sinus opacification and lower airway mucus plugs and wall thickening in asthma: a two-cohort computed tomography study

    Respir Med. 263: 109159, 2026

次ページへ » もっと見る